Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

GLYBURIDE

GLYBURIDE

Standard Dose
3MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview GLYBURIDE is listed in Drugs@FDA under application 075947 (ANDA).

Marketing status: Discontinued Active ingredient GLYBURIDE Form and strength TABLET;ORAL - 3MG Sponsor ACTAVIS ELIZABETH Submission history Latest submission status date: 2002-11-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview GLYBURIDE is listed in Drugs@FDA under application 075947 (ANDA). Marketing status: Discontinued Active ingredient GLYBURIDE Form and strength TABLET;ORAL - 3MG Sponsor ACTAVIS ELIZABETH Submission history Latest submission status date: 2002-11-14 00:00:00. Submission type: ORIG.

Monitoring

  • Review priority: STANDARD
  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.